Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MDXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 12.60M
March 31, 2026 1.901M
December 31, 2025 0.051M
September 30, 2025 0.083M
June 30, 2025 0.526M
March 31, 2025 2.458M
December 31, 2024 0.031M
September 30, 2024 -0.278M
June 30, 2024 0.105M
March 31, 2024 1.386M
December 31, 2023 8.924M
September 30, 2023 -0.386M
June 30, 2023 -0.02M
March 31, 2023 0.00
December 31, 2022 -0.078M
September 30, 2022 -0.137M
June 30, 2022 -0.271M
March 31, 2022 1.025M
December 31, 2021 -0.033M
September 30, 2021 0.143M
June 30, 2021 0.903M
March 31, 2021 2.301M
December 31, 2020 0.79M
September 30, 2020 -93.43M
June 30, 2020 2.33M
Date Value
March 31, 2020 -0.298M
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 -0.108M
March 31, 2019 0.00
December 31, 2018 -0.001M
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 4.018M
December 31, 2017 23.83M
September 30, 2017 26.89M
June 30, 2017 -5.249M
March 31, 2017 10.80M
December 31, 2016 -0.946M
September 30, 2016 6.316M
June 30, 2016 -0.878M
March 31, 2016 2.392M
December 31, 2015 18.00M
September 30, 2015 3.703M
June 30, 2015 2.881M
March 31, 2015 11.02M
December 31, 2014 -0.9174M
September 30, 2014 0.0405M
June 30, 2014 4.126M
March 31, 2014 -1.220M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 0.643M
Perspective Therapeutics, Inc. -0.16M
ABVC BioPharma, Inc. 0.00
Enovis Corp. -0.38M
Edwards Lifesciences Corp. -0.50M